December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Breelyn Wilky on botensilimab and balstilimab for refractory sarcomas at ESMO24
Sep 15, 2024, 00:29

Breelyn Wilky on botensilimab and balstilimab for refractory sarcomas at ESMO24

Agenus shared on LinkedIn:

Breelyn Wilky, presented new data at ESMO24 highlighting the potential of our investigational immunotherapy combination, botensilimab and balstilimab, for treating patients with refractory sarcomas.

Learn more about this advancement.”

Source: Agenus/LinkedIn